BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, February 16, 2026
Home » Authors » Khawar Khan

Articles by Khawar Khan

Conundrum: Pakistan relies on smuggled drugs from India

June 26, 2017
By Khawar Khan
KARACHI, Pakistan – Despite strict laws by the Drug Regulatory Authority of Pakistan that make smuggling medicines into the country a crime punishable by a maximum sentence of 10 years' imprisonment, the problem remains rife.
Read More

Lack of free market policies pushes biopharmas away from Pakistan

May 24, 2017
By Khawar Khan
KARACHI, Pakistan – Facing a chronic lack of regulation, the pharmaceutical industry in Pakistan is struggling to put in place a free market policy to boost the sector and provide quality drugs to a population of more than 200 million.
Read More

Lack of free market policies pushes biopharmas away from Pakistan

May 18, 2017
By Khawar Khan
KARACHI, Pakistan – Facing a chronic lack of regulation, the pharmaceutical industry in Pakistan is struggling to put in place a free market policy to boost the sector and provide quality drugs to a population of over 200 million.
Read More

Pakistan introduces first mobile diagnosis technology that provides rapid test results

April 18, 2017
By Khawar Khan

Pakistan's lack of med tech a cost burden

March 17, 2017
By Khawar Khan

Pakistan's biopharma sector struggles to establish regulations

Feb. 14, 2017
By Khawar Khan
KARACHI, Pakistan – Facing a chronic shortage of regulations, the biopharmaceutical industry in Pakistan is struggling to get traction despite widespread need and huge market potential. With a population that is rapidly approaching 200 million, Pakistan's pharmaceutical sector sees high growth potential, but it's held back by a lack of regulations that often translates into chronic shortages of essential medicines.
Read More

In Pakistan, 'informal' clinical trials raise ethics concerns

Jan. 26, 2017
By Khawar Khan
KARACHI, Pakistan – The death of 57-year-old Javed Iqbal in a private hospital in Karachi, Pakistan's economic hub, has shined a light on growing concerns surrounding clinical trials involving this country of 200 million people. Informal and often unethical clinical trials carried out by doctors are a common problem, according to numerous anecdotal reports.
Read More
Previous 1 2 3 4 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing